Mkts

Anika Therapeutics Inc.

NASDAQ: ANIK
$14.55-4.78 (-24.73%)
As of Nov 6, 4:00 PM ET

Key statistics

Day range
13.9017.88
52-week range
9.0122.88
Today
Open17.87
Previous close14.55
Volume59.2K
Valuation
Market cap214.80M
P/E ratio—
EPS (TTM)-0.27
Income & risk
Dividend / yield—
Beta0.25
Avg volume99.0K
Discussion

ANIK News

Stories mentioning ANIK from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue29,61230,61527,81728,21926,16830,60229,55930,724
Cost of Goods Sold10,61511,43612,23313,85611,48713,47610,15110,235
Gross Profit18,99719,17915,58414,36314,68117,12619,40820,489
Operating Expenses
Research & Development6,7136,4526,9466,3136,0596,5075,9466,682
Sales General & Admin17,77212,08111,87112,23012,90611,32413,54315,617
Total Operating Expenses
Operating Income (Loss)(5,488)646.00(3,233)(4,180)(4,284)(705.00)(81.00)(1,810)
Interest Income
Interest Expense
Other Expense
Pretax Income(4,821)764.00(2,236)(3,966)(3,869)39.00325.00(1,215)
Tax Provision235.00(1,037)939.00681.0089.002,5252,1701,326
Net Income (Loss)(5,056)292.00(2,329)(3,970)(4,873)(21,865)(29,918)(88.00)
Earnings Per Share (Basic)(0.37)0.02(0.16)(0.28)(0.34)(1.49)(2.03)(0.01)
Earnings Per Share (Diluted)(0.37)0.02(0.16)(0.28)(0.34)(1.49)(2.03)0.00
Weighted Average Shares Outstanding (Basic)13,53114,33914,41914,36414,29714,72114,76814,839
Weighted Average Shares Outstanding (Diluted)13,53114,33914,41914,51714,29714,72114,76814,856

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ANIK

Anika Therapeutics Inc. (NASDAQ: ANIK) is a stock listed on the Nasdaq Stock Market under the ticker symbol ANIK. It last traded at $14.55 (Nov 6, 2026, 4:00 PM ET), down 24.7% on the day. That gives Anika Therapeutics a market capitalisation of $214.8M.

Over the past 52 weeks ANIK has traded between $9.01 and $22.88.

Revenue for the quarter ended Mar 31, 2026 was $29.6M; a net loss of $5.1M. Revenue was up 13.2% from $26.2M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$29.6M-$5.1M-17.1%
Dec 31, 2025$30.6M$292.0K1.0%
Sep 30, 2025$27.8M-$2.3M-8.4%
Jun 30, 2025$28.2M-$4.0M-14.1%

From Anika Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…